Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
Open Access
- 1 July 2009
- journal article
- Published by Informa UK Limited in Patient Preference and Adherence
- Vol. 3, 173-177
- https://doi.org/10.2147/PPA.S3682
Abstract
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate L Bellamy1, N Rosencher1, BI Eriksson21Anaesthesiology Department, Hôpital Cochin (AP-HP), René Descartes University, Paris 75014 France; 2Orthopaedic Department, University Hospital Sahlgrenska/Ostra, Gothenburg, Sweden The recent development of new oral anticoagulants, of which dabigatran etexilate is currently at the most advanced stage of development, is the greatest advance in the provision of convenient anticoagulation therapy for many years. A new oral anticoagulation treatment, dabigatran etexilate, is already on the market in Europe. The main interest probably will be to improve the prescription and the adherence to an effective thromboprophylaxis in medical conditions such as atrial fibrillation without bleeding side effects, without the need for monitoring coagulation, and without drug and food interactions such as vitamin K anticoagulant (VKA) treatment. Dabigatran is particularly interesting for extended thromboprophylaxis after major orthopedic surgery in order to avoid daily injection for a month. However, oral long-term treatments such as VKA are not systematically associated with a higher compliance level than injected treatments such as low-molecular-weight heparins. Indeed, adherence to an oral treatment, instead of the usual daily injection in major orthopedic surgery, is complex, and based not only on the frequency of dosing but also on patient motivation, understanding, and socio-economic status. New oral anticoagulants may be useful in this way but education and detection of risk factors of nonadherence to treatment are still essential.Keywords: oral anticoagulant, adherence, compliance, education, dabigatranKeywords
This publication has 28 references indexed in Scilit:
- Prevention of Venous ThromboembolismChest, 2008
- Improved performance in activities of daily living and mobility after a multidisciplinary postoperative rehabilitation in older people with femoral neck fracture: a randomized controlled trial with 1-year follow-upJournal of Rehabilitation Medicine, 2007
- Outcomes of Oral Anticoagulant Therapy Managed by Telephone vs In-Office Visits in an Anticoagulation Clinic SettingChest, 2006
- Inpatient Rehabilitation Outcome After Hip Fracture Surgery in Elderly Patients: A Prospective Cohort Study of 946 PatientsArchives Of Physical Medicine and Rehabilitation, 2006
- Predictors of Noncompliance with Warfarin Therapy in an Outpatient Anticoagulation ClinicPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005
- Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE studyJournal of Thrombosis and Haemostasis, 2005
- A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trialJournal of Thrombosis and Haemostasis, 2005
- Perioperative plasma erythropoietin levels in hip arthroplastyAnnals of Hematology, 1994
- Feedback on Medication Dosing Enhances Patient ComplianceChest, 1993
- Simplified Enrollment for Autologous Transfusion: Automatic Referral of Presurgical Patients for Assessment for Autologous Blood CollectionsMayo Clinic Proceedings, 1992